Edition:
India

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.59USD
12:10am IST
Change (% chg)

$-0.02 (-0.77%)
Prev Close
$2.61
Open
$2.59
Day's High
$2.68
Day's Low
$2.50
Volume
15,504
Avg. Vol
24,993
52-wk High
$7.15
52-wk Low
$1.85

Latest Key Developments (Source: Significant Developments)

Pernix Therapeutics files for mixed shelf offering of up to $150 mln
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Pernix Therapeutics Holdings Inc ::Pernix Therapeutics Holdings files for mixed shelf offering of up to $150 million - SEC filing‍​.  Full Article

Pernix Therapeutics posts Q3 revenue of $40.5 mln
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Pernix Therapeutics Holdings Inc :Pernix Therapeutics reports third quarter 2017 financial results.Q3 revenue fell 2 percent to $40.5 million.  Full Article

Pernix Therapeutics announces sale of non-core product
Tuesday, 7 Nov 2017 

Nov 6 (Reuters) - Pernix Therapeutics Holdings Inc :Pernix Therapeutics announces sale of non-core product.Pernix Therapeutics Holdings Inc - ‍sale of a non-core product Cedax to SI Pharmaceuticals LLC, for $2 million in gross cash proceeds​.  Full Article

Pernix reports reverse stock split and corporate governance enhancements
Thursday, 13 Oct 2016 

Pernix Therapeutics Holdings Inc : Pernix Therapeutics announces reverse stock split and corporate governance enhancements . Pernix Therapeutics Holdings Inc - trading on post-split basis on nasdaq commencing at open of stock market on October 14, 2016 .Pernix Therapeutics Holdings Inc- board of directors unanimously approved a reverse split of its common stock at a ratio of 1-for-10.  Full Article

Pernix Therapeutics qtrly net loss per common share $0.47
Friday, 12 Aug 2016 

Pernix Therapeutics Holdings Inc : Pernix therapeutics reports second quarter 2016 financial results and business update . Pernix therapeutics holdings inc q2 revenue $36.7 mln vs i/b/e/s view $40.3 mln .Pernix therapeutics holdings inc qtrly net loss per common and potential common share $0.47.  Full Article

Pernix Therapeutics announces reorganization of Senior Management Team
Wednesday, 27 Jul 2016 

Pernix Therapeutics Holdings Inc : Says graham miao appointed CFO and President . Pernix Therapeutics announces reorganization of senior management team . Pernix Therapeutics Holdings Inc says John Sedor will assume role of Chief Executive Officer on a permanent basis .Sanjay Patel, CFO, Terence Novak, COO, and Barry Siegel, Senior Vice President and General Counsel are no longer employed by Pernix..  Full Article

Pernix Therapeutics appointed John A. Sedor as CEO
Wednesday, 27 Jul 2016 

Pernix Therapeutics Holdings Inc : On July 21 board appointed John A. Sedor as company's chief executive officer, effective July 26, 2016 - SEC filing . On July 21, 2016, the board appointed Graham Miao as the company's president and chief financial officer .Company will pay Miao a salary of $41,750 per month.  Full Article

Pernix Therapeutics says restructuring sales force
Thursday, 7 Jul 2016 

Pernix Therapeutics Holdings Inc : Pernix therapeutics announces restructuring of sales force and operations . Pernix has reduced its total full-time work force by approximately 23 percent . Anticipates reorganization will result in an estimated annualized cost savings of about $10 million, beginning in Q3 2016 . As of Thursday, Pernix remains in compliance with all covenants in its debt facilities . Reorganization plan includes consolidation of neurology, pain sales forces under one sales management structure . Expects to take a one-time charge of approximately $2 million in Q3 of 2016 in connection with reorganization .Anticipates making its interest and principal payment on company's senior secured notes on August 1, 2016.  Full Article

BRIEF-Pernix Therapeutics files for mixed shelf offering of up to $150 mln

* Pernix Therapeutics Holdings files for mixed shelf offering of up to $150 million - SEC filing‍​ Source text: (http://bit.ly/2jg0Ica) Further company coverage: